Toray Industries, Inc. and Sanodyne Therapeutics, Inc. announced today that they have entered into an exclusive worldwide license agreement granting Sanodyne the rights to develop, manufacture, and market TRK-750 (Toray code name), a drug candidate under development to treat peripheral neuropathy and neuropathic pain. Sanodyne will continue its R&D under the code name SNT-001.

For further details, please check the link below.